A critical discovery in cancer research is occurring with the use of mini-antibodies to re-engage dysfunctional p53. This essential tumor protector protein is frequently inactivated in many kinds of cancer, resulting https://bookmarkinglog.com/story21987319/mini-antibodies-revive-tumor-suppressor-p53-a-new-pathway-for-tumor-therapy